Inhaled receptor decoy therapy for COVID-19 in preclinical models

Inhalon Biopharma - Study For Inhaled COVID-19 Antibody TherapyПодробнее

Toru Okamoto: Development of an engineered ACE2 decoy for the treatment of COVID-19Подробнее

IL-6 Receptor Blockers In COVID-19 | WHO Latest Recommendation 🔥💚Подробнее

Cell Therapy Treatments for COVID-19Подробнее

Therapeutic strategies for early covid 19- recent updates with focus on inhaled BudesonideПодробнее

Aviptadil Works For SEVERE COVID-19 PatientsПодробнее

Decoy protein injection could stop COVID-19 - University of LeicesterПодробнее

Aridis Pharmaceuticals reveals exciting preclinical data for its inhaled coronavirus treatmentПодробнее

Medical Misinformation | Dr Lora Shahine #vaccinated #covid19Подробнее

Inflammation and Toll-like receptors - COVID-19 Vaccines Update 48Подробнее

Procalcitonin as an Aid for Risk Assessment in COVID-19 (SARS-CoV-2) and Influenza Related SecondaryПодробнее

Potential COVID-19 Treatments Using Cell TherapiesПодробнее

AVIPTadilПодробнее

Efforts by the OTS community to combat SARS-CoV-2 and COVID-19Подробнее

Michel Nussenzweig: "Fighting COVID-19 with Neutralizing Antibodies"Подробнее

Targeting respiratory viruses: A novel alveolus-on-chip infection model for preclinical applicationsПодробнее

BioCT Virtual Panel Discussion "COVID-19: Current Pipeline & Innovations for Therapeutics & Vaccine"Подробнее

Inflammation In The Brain After COVID-19 | Dr. Daniel AmenПодробнее

Trials start for inhaled version of remdesivirПодробнее